Open Heart

NOVEMBER 25, 2022

UA) independently predicted the combined endpoint (left ventricular assist device, total artificial heart implantation, heart transplantation or all-cause mortality) (hazard ratio (HR): 1.10 (1.03–1.17), p=0.004) as well as all-cause mortality (HR: 1.15 (1.06–1.25), p=0.001).

Heart Failure 52

Heart Failure Outcomes Heart Transplant Artificial Heart 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

The Annals of Thoracic Surgery September 2016 Marshall Jacobs The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2016 Update on Research The Annals of Thoracic Surgery September 2016 Lawrence Schwartz The Perioperative Use of Dexmedetomidine in Pediatric Patients with Congenital Heart Disease: An Analysis from the Congenital Cardiac (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

The Annals of Thoracic Surgery September 2016 Marshall Jacobs The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2016 Update on Research The Annals of Thoracic Surgery September 2016 Lawrence Schwartz The Perioperative Use of Dexmedetomidine in Pediatric Patients with Congenital Heart Disease: An Analysis from the Congenital Cardiac (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52